Ardent Health (NYSE:ARDT) Raised to Hold at Zacks Research

by · The Cerbat Gem

Ardent Health (NYSE:ARDT – Get Free Report) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports.

Other equities analysts also recently issued research reports about the stock. Weiss Ratings downgraded shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 11th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $13.00 price target on shares of Ardent Health in a report on Thursday, August 6th. Guggenheim increased their price target on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Finally, Truist Financial lifted their price objective on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $13.05.

Get Our Latest Stock Analysis on Ardent Health

Ardent Health Trading Down 1.6%

Ardent Health stock opened at $10.74 on Monday. The stock has a market cap of $1.51 billion, a PE ratio of 19.53, a P/E/G ratio of 3.09 and a beta of 0.71. The stock has a 50-day moving average price of $10.74 and a 200 day moving average price of $9.83. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The firm had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities research analysts predict that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd boosted its position in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after purchasing an additional 2,638 shares during the period. Allworth Financial LP acquired a new position in shares of Ardent Health during the second quarter worth about $28,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Ardent Health in the second quarter worth about $57,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Ardent Health in the third quarter valued at about $61,000. Finally, Monetary Solutions Ltd purchased a new stake in shares of Ardent Health during the 4th quarter valued at about $79,000.

About Ardent Health

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

Featured Articles